EDAP TMS | EDAP - Selling And Administration Expenses

Stock Price
3.22
Daily Change
-0.07 -2.13%
Monthly
-13.21%
Yearly
50.47%
Q2 Forecast
3.15

EDAP TMS reported EUR8.81M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
AngioDynamics USD 36.57M 3.79M Sep/2025
Boston Scientific USD 1.83B 93M Dec/2025
EDAP TMS EUR 8.81M 1.57M Sep/2025
Henry Schein USD 808M 48M Dec/2025
Medtronic 2.97B 159M Sep/2025
Plus Therapeutics USD 3.49M 559K Dec/2025
Veracyte USD 43.31M 8.43M Dec/2025